(Q43272249)

18 November 2017

Pharmacokinetics of sulfadoxine and pyrimethamine in intermittent preventive treatment of malaria in pregnancy (English)

1 reference

pregnancy-associated malaria

18 November 2017

0 references

0 references

0 references

1 reference

1 reference

E Guirou

9

0 references

Boubacar Traore

10

object named as

B Traore

1 reference

18 November 2017

11

O Doumbo

1 reference

18 November 2017

M M Nyunt

1

1 reference

18 November 2017

I Adam

2

1 reference

18 November 2017

K Kayentao

3

1 reference

18 November 2017

J van Dijk

4

1 reference

18 November 2017

P Thuma

5

1 reference

18 November 2017

K Mauff

6

1 reference

18 November 2017

F Little

7

1 reference

18 November 2017

Y Cassam

8

1 reference

18 November 2017

D Sullivan

12

1 reference

18 November 2017

P Smith

13

1 reference

18 November 2017

K I Barnes

14

1 reference

18 November 2017

language of work or name

English

0 references

publication date

23 September 2009

1 reference

Clinical Pharmacology & Therapeutics

18 November 2017

1 reference

18 November 2017

87

1 reference

18 November 2017

226-234

1 reference

18 November 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1038/clpt.2009.177

18 November 2017

0 references

cites work

Pharmacokinetics and protein binding interactions of dapsone and pyrimethamine

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.177

Pyrimethamine pharmacokinetics and its tissue localization in mice: effect of dose size.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.177

The efficacy of antimalarial regimens containing sulfadoxine-pyrimethamine and/or chloroquine in preventing peripheral and placental Plasmodium falciparum infection among pregnant women in Malawi.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.177

7 January 2021

Efficacy of sulfadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.177

7 January 2021

Intermittent sulphadoxine-pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.177

7 January 2021

Prevention of anaemia in pregnancy using insecticide-treated bednets and sulfadoxine-pyrimethamine in a highly malarious area of Kenya: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.177

7 January 2021

Intermittent presumptive treatment for malaria

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.177

7 January 2021

Determination of plasma concentrations of dapsone, monoacetyl dapsone and pyrimethamine in human subjects dosed with maloprim

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.177

7 January 2021

The disposition of pyrimethamine base and pyrimethamine pamoate in the mouse: effect of route of administration

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.177

7 January 2021

Pharmacokinetics of sulfadoxine and pyrimethamine after Fansidar administration in man.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.177

7 January 2021

Sulfadoxine-pyrimethamine pharmacokinetics in malaria: pediatric dosing implications.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.177

7 January 2021

Serial changes in renal haemodynamics during normal human pregnancy

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.177

7 January 2021

Renal hemodynamics and tubular function normal human pregnancy

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.177

7 January 2021

The effect of pregnancy on the renal handling of glucose

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.177

7 January 2021

24-hour creatinine clearance during the third trimester of normal pregnancy

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.177

7 January 2021

The disposition of pyrimethamine in the isolated perfused rat liver

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.177

7 January 2021

Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.177

7 January 2021

Pharmacokinetics of Sulfadoxine-Pyrimethamine in HIV-Infected and Uninfected Pregnant Women in Western Kenya

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.177

7 January 2021

Genetic polymorphism of drug metabolising enzymes in African populations: implications for the use of neuroleptics and antidepressants

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.177

7 January 2021

Association between the pharmacokinetics and in vivo therapeutic efficacy of sulfadoxine-pyrimethamine in Malawian children

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.177

7 January 2021

The susceptibility of Plasmodium falciparum to sulfadoxine and pyrimethamine: correlation of in vivo and in vitro results.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.177

7 January 2021

Combination of drug level measurement and parasite genotyping data for improved assessment of amodiaquine and sulfadoxine-pyrimethamine efficacies in treating Plasmodium falciparum malaria in Gabonese children

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.177

7 January 2021

Integrated vector management: the Zambian experience

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.177

7 January 2021

Seven years of regional malaria control collaboration--Mozambique, South Africa, and Swaziland.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2009.177

7 January 2021

Identifiers

DOI

10.1038/CLPT.2009.177

1 reference

Dimensions Publication ID

18 November 2017

0 references

1 reference